StockData

Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.12−0.16 (-12.50%)

Close on Nov 17, 2026Market cap $9.38MP/E –Yield –

Femasys revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Femasys's revenue for the twelve months ending Jun 30, 2026 was $2.30M, up 21.9% year over year. For fiscal 2025 it was $2.29M, up 40.8% from the year before. The highest annual figure on record is $2.29M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.29M+40.8%
FY2024Dec 31, 2024$1.63M+52.0%
FY2023Dec 31, 2023$1.07M-11.1%
FY2022Dec 31, 2022$1.21M+2.2%
FY2021Dec 31, 2021$1.18M+13.7%
FY2020Dec 31, 2020$1.04M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$331.83K-18.9%
Q1 FY2026Mar 31, 2026$424.89K+24.5%
Q4 FY2025Dec 31, 2025$813.39K+39.9%
Q3 FY2025Sep 30, 2025$729.39K+31.4%
Q2 FY2025Jun 30, 2025$409.27K+84.8%
Q1 FY2025Mar 31, 2025$341.26K+25.9%
Q4 FY2024Dec 31, 2024$581.58K+172.9%
Q3 FY2024Sep 30, 2024$554.91K+127.1%
Q2 FY2024Jun 30, 2024$221.48K-30.9%
Q1 FY2024Mar 31, 2024$271.14K-7.8%
Q4 FY2023Dec 31, 2023$213.11K-9.0%
Q3 FY2023Sep 30, 2023$244.36K-29.7%
Q2 FY2023Jun 30, 2023$320.51K+5.7%
Q1 FY2023Mar 31, 2023$293.98K-8.5%
Q4 FY2022Dec 31, 2022$234.24K-7.9%
Q3 FY2022Sep 30, 2022$347.46K+28.9%
Q2 FY2022Jun 30, 2022$303.11K-7.0%
Q1 FY2022Mar 31, 2022$321.41K-2.5%
Q4 FY2021Dec 31, 2021$254.33K-9.5%
Q3 FY2021Sep 30, 2021$269.58K-13.9%
Q2 FY2021Jun 30, 2021$326.01K+77.9%
Q1 FY2021Mar 31, 2021$329.78K–
Q4 FY2020Dec 31, 2020$280.96K–
Q3 FY2020Sep 30, 2020$313.21K–
Q2 FY2020Jun 30, 2020$183.23K–

More Femasys figures

See a number that looks wrong?